Cargando…

Plasma diamine oxidase level predicts 6-month readmission for patients with hepatitis B virus-related decompensated cirrhosis

BACKGROUND AND AIMS: Hepatitis B virus-related decompensated cirrhosis is difficult to cure but has a high readmission rate due to multiple complications. Our aim was to investigate the diagnostic potential value of plasma diamine oxidase (DAO) for 6-month readmission of patients with HBV-related de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Feng-Cai, Fan, Yu-Chen, Li, Yue-Kai, Wang, Kai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751599/ https://www.ncbi.nlm.nih.gov/pubmed/31533748 http://dx.doi.org/10.1186/s12985-019-1219-4

Ejemplares similares

Serum lactate level predicts 6-months mortality in patients with hepatitis B virus-related decompensated cirrhosis: a retrospective study
por: Nie, Yuan, et al.
Publicado: (2021)

Randomized intervention and outpatient follow-up lowers 30-d readmissions for patients with hepatic encephalopathy, decompensated cirrhosis
por: Pusateri, Antoinette, et al.
Publicado: (2023)

Polyamine Oxidase and Diamine Oxidase Activities in Human Milk during the First Month of Lactation
por: Bjelakovic, Ljiljana, et al.
Publicado: (2012)

Treatment of Hepatitis B in Decompensated Liver Cirrhosis
por: Guan, Richard, et al.
Publicado: (2011)

Splenectomy prior to antiviral therapy in patients with hepatitis C virus related decompensated cirrhosis
por: Ji, Fanpu, et al.
Publicado: (2013)

Risk Stratification Score to Predict Readmission of Patients With Acute Decompensated Cirrhosis Within 90 Days
por: Xu, Xiaomei, et al.
Publicado: (2021)

Comparison of the Prognosis of Decompensated Cirrhosis in Patients with and Without Eradication of Hepatitis C Virus
por: Kumada, Takashi, et al.
Publicado: (2021)

Proton pump inhibitor use increases mortality and hepatic decompensation in liver cirrhosis
por: De Roza, Marianne Anastasia, et al.
Publicado: (2019)

Lack of Association of Plasma Histamine with Diamine Oxidase in Chronic Idiopathic Urticaria
por: Cho, Hee Jin, et al.
Publicado: (2013)

SACRED: Effect of simvastatin on hepatic decompensation and death in subjects with high-risk compensated cirrhosis: Statins and Cirrhosis: Reducing Events of Decompensation
por: Kaplan, David E., et al.
Publicado: (2021)

Multivariate metabotyping of plasma predicts survival in patients with decompensated cirrhosis
por: McPhail, Mark J.W., et al.
Publicado: (2016)

Changes in serum concentration and activity of diamine oxidase during the first month of life in calves
por: ONO, Mamiko, et al.
Publicado: (2023)

Resolution of ascites and hepatic encephalopathy and absence of variceal bleeding in decompensated hepatitis C virus cirrhosis patients
por: Romano, John, et al.
Publicado: (2018)

Serum liver fibrosis markers predict hepatic decompensation in compensated cirrhosis
por: Chen, Qingling, et al.
Publicado: (2023)

Recompensation of Decompensated Hepatitis B Cirrhosis: Current Status and Challenges
por: Zhao, Hong, et al.
Publicado: (2020)

Evolution of care in cirrhosis: Preventing hepatic decompensation through pharmacotherapy
por: Lee, Seohyuk, et al.
Publicado: (2023)

Usefulness of International Normalized Ratio to Albumin Ratio for Evaluation of Mortality in Hepatitis B Virus-Associated Decompensated Cirrhosis
por: Cai, Ming, et al.
Publicado: (2021)

Rescue therapy with adefovir in decompensated liver cirrhosis patients with lamivudine-resistant hepatitis B virus
por: Woo, Hyun Young, et al.
Publicado: (2014)

Improving Survival in Decompensated Cirrhosis
por: Mukerji, Amar Nath, et al.
Publicado: (2012)

Management options in decompensated cirrhosis
por: Shah, Neeral L, et al.
Publicado: (2015)

COVID-19 in decompensated cirrhosis
por: Rela, Mohamed, et al.
Publicado: (2020)

Decompensation of Cirrhosis: An Unusual Cause
por: Rudra, Omkar S, et al.
Publicado: (2022)

Low Prealbumin Levels Were Associated with Increased Frequency of Hepatic Encephalopathy in Hepatitis B Virus (HBV)-Related Decompensated Cirrhosis
por: Li, Jiani, et al.
Publicado: (2023)

Entecavir for Patients with Hepatitis B Decompensated Cirrhosis in China: a meta-analysis
por: Wang, F.Y., et al.
Publicado: (2016)

Predictors of Three-month Hospital Readmissions and Mortality in Patients with Cirrhosis of Liver
por: Lavekar, Anurag, et al.
Publicado: (2019)

Platelet-to-Monocyte Ratio as a Novel Promising Agent for the Prognosis of Hepatitis B Virus-Associated Decompensated Cirrhosis
por: Zhou, Jun, et al.
Publicado: (2023)

Hepatic Myelopathy in a Patient with Decompensated Alcoholic Cirrhosis and Portal Colopathy
por: Premkumar, Madhumita, et al.
Publicado: (2012)

Serum Sphingolipid Variations Associate with Hepatic Decompensation and Survival in Patients with Cirrhosis
por: Grammatikos, Georgios, et al.
Publicado: (2015)

Sofosbuvir and ribavirin in acute hepatitis C–infected patient with decompensated cirrhosis
por: Liu, Hui, et al.
Publicado: (2016)

Invasive pulmonary mucormycosis and aspergillosis in a patient with decompensated hepatic cirrhosis
por: Persichino, Jon G., et al.
Publicado: (2018)

Safety and efficacy of tenofovir in chronic hepatitis B-related decompensated cirrhosis
por: Lee, Soon Kyu, et al.
Publicado: (2017)

Postoperative Risk of Hepatic Decompensation after Orthopedic Surgery in Patients with Cirrhosis
por: Nyberg, Eric M., et al.
Publicado: (2016)

Antiviral Therapy in Chronic Hepatitis C Virus-related Decompensated Liver Cirrhosis – A Tightrope Walk
por: Amarapurkar, Deepak N.
Publicado: (2010)

Effects of Entecavir and Tenofovir on Renal Function in Patients with Hepatitis B Virus-Related Compensated and Decompensated Cirrhosis
por: Park, Jihye, et al.
Publicado: (2017)

New prognostic factor for hepatitis B virus‐related decompensated cirrhosis: Ratio of monocytes to HDL‐cholesterol
por: Wu, Qianxia, et al.
Publicado: (2021)

Innumerable cerebral microbleeds in hepatitis B virus-related decompensated liver cirrhosis: a case report
por: Oh, Chi Hyuk, et al.
Publicado: (2021)

Efficacy and Safety of Sofosbuvir/Velpatasvir Plus Ribavirin in Patients with Hepatitis C Virus-Related Decompensated Cirrhosis
por: Flamm, Steven, et al.
Publicado: (2023)

Evaluation of five lymphocyte-based scores for prediction of mortality in hepatitis B virus-associated decompensated cirrhosis
por: Mao, Ting, et al.
Publicado: (2023)

P-49 COVID 19-PANDEMIC AND OUTCOMES IN DECOMPENSATE CIRRHOSIS-10 MONTHS REVIEW
por: Pollo-Flores, Priscila, et al.
Publicado: (2021)

Outcomes after sofosbuvir-containing regimens for hepatitis C virus in patients with decompensated cirrhosis: a real-world study
por: Ji, Fanpu, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_dkicf5ndii101g022n8ifh3ju5